Rituximab versus an alternative TNF inhibitor in patients with ...

Rituximab versus an alternative TNF inhibitor in patients ... - PubMed

These real-life data indicate that, after discontinuation of an initial TNFi, switching to rituximab is associated with significantly improved clinical ...

Data from a Swiss registry also indicated that rituximab treatment led to better clinical outcomes in TNF-IR patients than an alternative TNF ...

Rituximab versus an alternative TNF inhibitor in patients with ...

Objectives To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid arthritis ( ...

Comparative effectiveness and safety of rituximab versus ...

The addition of rituximab and other non-anti-TNF agents to the anti-RA armamentarium has increased the treatment options available to patients ...

Rituximab versus tocilizumab in anti-TNF inadequate responder ...

Because more than 50% of patients with rheumatoid arthritis have low or absent CD20 B cells—the target for rituximab—in the main disease tissue ...

(PDF) Rituximab versus an alternative TNF inhibitor in patients with ...

The overall incidence of adverse events was similar between the rituximab and TNFi groups. CONCLUSIONS: These real-life data indicate that, after ...

SWITCH-RA, a global, observational, comparative effectiveness study.

Request PDF | Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: ...

Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis ...

Whether it is attributable to a primary or secondary treatment failure, as many as 60% of patients may have an inadequate response to anti-TNF ...

Compared efficacy of rituximab, abatacept, and tocilizumab in ...

Traditionally used as a first-line treatment after methotrexate (MTX) failure, therapy with tumor necrosis factor inhibitors (TNFi) improves the ...

Rituximab versus anti-TNF in patients who previously failed one TNF ...

Results: A total of 328 patients who failed an anti-TNF switched to an alternative biologic, 69 to RTX, 161 to an anti-TNF monoclonal ...

VARIAR Study: Assessment of Short-term Efficacy and Safety of ...

To compare the short-term efficacy and safety of rituximab (RTX) therapy versus anti-TNF in rheumatoid arthritis (RA) patients after discontinuation of a first ...

Rituximab versus an alternative TNF inhibitor in patients with ... - OUCI

ObjectivesTo compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid ...

Rituximab Equally Effective, Less Costly Than TNF Inhibitors in RA

In prior studies, TNF inhibitors and rituximab had similar efficacy in treating patients with RA who had not responded to non-biologic disease ...

RA: Rituximab Preferred After TNF Inhibitor Failure - Medscape

After TNF inhibitor failure, patients with rheumatoid arthritis generally did better if switched to rituximab rather than to an alternative ...

Comparison of rituximab and TNF inhibitors in rheumatoid arthritis

Studies have shown that about 40% patients fail to respond to this therapy. Treatment failure may be due to non-response (drug does not have an ...

Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated ...

Meaning Short- to medium-term use of tocilizumab, abatacept, rituximab, or anti-TNF drugs seems to be safe with regard to risks of incident ...

Rituximab versus an alternative TNF inhibitor in ... - H1 Connect

This prospective observational study showed an overall similar incidence of adverse events in patients non-responsive or intolerant to a single anti-tumor ...

Rituximab versus anti-TNF in patients who previously failed one TNF ...

Results: A total of 328 patients who failed an anti-TNF switched to an alternative biologic, 69 to RTX, 161 to an anti-TNF monoclonal antibody ( ...

Rituximab is more effective than second anti-TNF therapy in ...

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and ... alternative tumor necrosis factor-α (TNFα) ...

[PDF] Comparing Effectiveness Rituximab (Mabthera®) to Other ...

Switching to rituximab or alternative anti-TNF agents after failure of the initial TNF antagonist showed no significant therapeutic ...